search
Back to results

Anaesthetic Depth and Short Term Delirium Post Cardiac Surgery Intervention (BISCAR)

Primary Purpose

Post-operative Delirium, Anaesthetic Depth

Status
Not yet recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
General anesthesia with propofol or sevoflurane
CAM-ICU (Confusion Assesment Method ICU) at day 3 post-operative
Sponsored by
Centre Cardiologique du Nord
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Post-operative Delirium

Eligibility Criteria

75 Years - 85 Years (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Patient aged between 75 and 85 years, who signed an informed consent, undergoing elective valvular, coronary artery bypass, aortic or combined cardiac surgery Be affiliated to French Health Insurance Exclusion Criteria: Refusal of consent -Patient unable to read, write or understand French Vulnerable patient according to article L1121-6 of the CSP, Patient of legal age under guardianship or curatorship or under legal protection, Patient unable to give personal consent according to article L.1121-8 of the CSP or adult protected by law, Patient having already participated in the present study

Sites / Locations

  • Centre cardiologique du nord

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Perioperative anesthesia with a BIS target of 35

Perioperative anesthesia with a BIS target of 55

Arm Description

Anesthesia with a BIS target of 35

Anesthesia with a BIS target of 55

Outcomes

Primary Outcome Measures

To demonstrate the benefit of reduced depth of anesthesia
The presence of mental confusion using CAM-ICU ( The Confusion Assessment Method for the Intensive Care Unit )

Secondary Outcome Measures

Full Information

First Posted
May 2, 2023
Last Updated
June 12, 2023
Sponsor
Centre Cardiologique du Nord
search

1. Study Identification

Unique Protocol Identification Number
NCT05877326
Brief Title
Anaesthetic Depth and Short Term Delirium Post Cardiac Surgery Intervention
Acronym
BISCAR
Official Title
Anaesthetic Depth and Short Term Delirium Post Cardiac Surgery Intervention
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
September 2023 (Anticipated)
Primary Completion Date
May 10, 2025 (Anticipated)
Study Completion Date
May 10, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Cardiologique du Nord

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Postoperative delirium (POD) is a critical complication of major surgery and affects up to 70% of surgical patients over the age of 60 years. The additional healthcare costs associated with delirium exceed €50,000 per patient per year due to prolonged hospital stay, increased risk of long-term care or institutionalization, and the risk of developing dementia or cognitive impairment . Therefore, prevention of POD is a major goal in the perioperative setting. The investigator proposes this randomized study to evaluate the interest of a reduced anesthetic depth to prevent short-term cognitive disorders after cardiac surgery in elderly subjects. Method: Patients over 75 years old scheduled to undergo one of the cardiac surgeries of interest (valvular, coronary bypass, aortic or combined surgery) will be randomized to 2 paralell arms : Perioperative anesthesia with a BIS (Bispectral index) target of 35 Perioperative anesthesia with a BIS(Bispectral index) target of 55 The presence of mental confusion will be determined by CAM-ICU ( Confusion Assessment Method for the ICU ) at day 3 post procedure. Ancillary study: To assess cognitive status at inclusion, discharge and third post operative month using the MOCA(Montreal Cognitive Assessment ). Conclusion:The hypothesis of this study is that a lower depth of anesthesia will reduce post operative delirium in the first three days in patients older than 75 years who are planned for valvular, coronary artery bypass, aortic or combined cardiac surgery .
Detailed Description
Multicenter, controlled, randomized trial with two parallel arms (Perioperative anesthesia with a BIS target of 35 / Perioperative anesthesia with a BIS target of 55). Randomization will be stratified by center, type of surgery (valve vs coronary artery bypass surgery vs aortic surgery vs combined surgery), patient age (75-80 vs 81-85), Euroscore 2 score at inclusion (predicted mortality risk ≥ vs < to 30%). An ancillary study with MOCA score measurement at inclusion, discharge and 3 months after cardiac surgery will be realized. Primary Objective: To demonstrate the benefit of lower anesthesia on the prevalence of delirium during the first 3 days postoperatively in patients aged 75 years and older having cardiac surgery (valvular, coronary bypass, aortic or combined surgery). Primary endpoint: Presence of mental confusion will be determined by CAM-ICU at day 3 post surgery. The CAM-ICU is considered POSITIVE (confusion present) if criteria 1 and 2 + 3 or 4 are met. Secondary objectives: To evaluate the effects of the intervention on ICU and hospital length of stay, delirium durations, mortality at month 3 , prevalence of POD during the stay, duration of mechanical ventilation, rate of reintubation,total amount of propofol, opioids and neuromuscular blockade (au lieu de curares) during anesthesia . Secondary endpoints: CAM ICU at times day 1, Day 2 , and Day 3 , daily doses of benzodiazepines, opiates, propofol, dexmedetomidine, and neuroleptics, days without mechanical ventilation, ICU and total lengths of stay, vital status (phone call) at Month 3, duration of delirium, total amount of propofol, opioids and neuromuscular blockade during anesthesia . In order to demonstrate a minimum difference in the confounding rate (according to CAM-ICU) of 20 points (50% expected in the BIS 35 arm versus 30% in the BIS 55 arm) and with a two-sided first-species risk of 5% and a minimum power of 80%, 186 analyzable subjects (93 per arm) are required. In order to take into account possible loss of sight, we propose to include in this study a total of 200 subjects (100 per arm).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Post-operative Delirium, Anaesthetic Depth

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Multicenter, controlled, randomized, two parallel-arm trial: Perioperative anesthesia with a BIS target of 35 Perioperative anesthesia with a 55% BIS target
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Perioperative anesthesia with a BIS target of 35
Arm Type
Active Comparator
Arm Description
Anesthesia with a BIS target of 35
Arm Title
Perioperative anesthesia with a BIS target of 55
Arm Type
Active Comparator
Arm Description
Anesthesia with a BIS target of 55
Intervention Type
Drug
Intervention Name(s)
General anesthesia with propofol or sevoflurane
Other Intervention Name(s)
General anesthesia with 35 BIS target or 55 BIS target
Intervention Description
General anesthesia
Intervention Type
Behavioral
Intervention Name(s)
CAM-ICU (Confusion Assesment Method ICU) at day 3 post-operative
Intervention Description
The presence of mental confusion will be determined by CAM-ICU at J3 post intervention.
Primary Outcome Measure Information:
Title
To demonstrate the benefit of reduced depth of anesthesia
Description
The presence of mental confusion using CAM-ICU ( The Confusion Assessment Method for the Intensive Care Unit )
Time Frame
Day 3 post intervention.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
75 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient aged between 75 and 85 years, who signed an informed consent, undergoing elective valvular, coronary artery bypass, aortic or combined cardiac surgery Be affiliated to French Health Insurance Exclusion Criteria: Refusal of consent -Patient unable to read, write or understand French Vulnerable patient according to article L1121-6 of the CSP, Patient of legal age under guardianship or curatorship or under legal protection, Patient unable to give personal consent according to article L.1121-8 of the CSP or adult protected by law, Patient having already participated in the present study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ellouze Omar, MD
Phone
0149337245
Email
ellouze.omar@yahoo.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Moussouni karima, CRA
Phone
0679145144
Email
K.MOUSSOUNI@CCN.FR
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ellouze Omar, MD
Organizational Affiliation
Centre Cardiologique du Nord
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre cardiologique du nord
City
Saint-Denis
ZIP/Postal Code
93200
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
The sponsor and the persons acting on its behalf will have access to the data. In addition, only the persons delegated by the investigating physician, health or research professionals, involved in the realization of the research and subject to professional secrecy, will have access to these coded data.

Learn more about this trial

Anaesthetic Depth and Short Term Delirium Post Cardiac Surgery Intervention

We'll reach out to this number within 24 hrs